Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Davis

Showing results (191-200 of 227) with videos related to

Pageof 23
Sort By:
Journal of Hepatology|June 1, 1995
Relationship between the presence of circulating anti-GOR and hepatitis C viremia/genotypeJ Y Lau, M Mizokami, G L Davis, et al.
The Journal of Biological Chemistry|June 5, 1990
Purification and characterization of recombinant plasminogen activator inhibitor-1 from Escherichia coliT M Reilly, R Seetharam, J L Duke, et al.
Journal of Viral Hepatitis|January 1, 1995
Variations of hepatitis C virus NS5B sequence (nucleotides 8261-8566) do not correlate with response to interferon-alpha therapyD R Nelson, A H Gray, J A Kolberg, et al.
The Journal of Infectious Diseases|August 1, 1997
Effect of interferon-alpha and ribavirin therapy on serum GB virus C/hepatitis G virus (GBV-C/HGV) RNA levels in patients chronically infected with hepatitis C virus and GBV-C/HGVJ Y Lau, K Qian, J Detmer, et al.
The American Journal of Cardiology|July 1, 1980
Retrospective analyses of the need for mechanical circulatory support (intrasortic balloon pump/abdominal left ventricular assist device or partial artificial heart) after cardiopulmonary bypass. A 44 month study of 14,168 patientsM G McGee, S L Zillgitt, R Trono, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2011
High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplantJ G O'Leary, H Kaneku, B M Susskind, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 26, 2001
Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantationD R Nelson, C Soldevila-Pico, A Reed, et al.
Lancet (London, England)|June 12, 1993
Significance of serum hepatitis C virus RNA levels in chronic hepatitis CJ Y Lau, G L Davis, J Kniffen, et al.
Hepatology (Baltimore, Md.)|November 1, 1993
Hepatitis C virus infection in kidney transplant recipientsJ Y Lau, G L Davis, M E Brunson, et al.
Cancer Research|July 1, 1987
Tumor-specific genetically engineered murine/human chimeric monoclonal antibodyB A Brown, G L Davis, J Saltzgaber-Muller, et al.
Pageof 23

Showing results (191-200 of 227) with videos related to

Sort By:
Pageof 23
Journal of Hepatology|June 1, 1995
Relationship between the presence of circulating anti-GOR and hepatitis C viremia/genotypeJ Y Lau, M Mizokami, G L Davis, et al.
The Journal of Biological Chemistry|June 5, 1990
Purification and characterization of recombinant plasminogen activator inhibitor-1 from Escherichia coliT M Reilly, R Seetharam, J L Duke, et al.
Journal of Viral Hepatitis|January 1, 1995
Variations of hepatitis C virus NS5B sequence (nucleotides 8261-8566) do not correlate with response to interferon-alpha therapyD R Nelson, A H Gray, J A Kolberg, et al.
The Journal of Infectious Diseases|August 1, 1997
Effect of interferon-alpha and ribavirin therapy on serum GB virus C/hepatitis G virus (GBV-C/HGV) RNA levels in patients chronically infected with hepatitis C virus and GBV-C/HGVJ Y Lau, K Qian, J Detmer, et al.
The American Journal of Cardiology|July 1, 1980
Retrospective analyses of the need for mechanical circulatory support (intrasortic balloon pump/abdominal left ventricular assist device or partial artificial heart) after cardiopulmonary bypass. A 44 month study of 14,168 patientsM G McGee, S L Zillgitt, R Trono, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2011
High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplantJ G O'Leary, H Kaneku, B M Susskind, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 26, 2001
Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantationD R Nelson, C Soldevila-Pico, A Reed, et al.
Lancet (London, England)|June 12, 1993
Significance of serum hepatitis C virus RNA levels in chronic hepatitis CJ Y Lau, G L Davis, J Kniffen, et al.
Hepatology (Baltimore, Md.)|November 1, 1993
Hepatitis C virus infection in kidney transplant recipientsJ Y Lau, G L Davis, M E Brunson, et al.
Cancer Research|July 1, 1987
Tumor-specific genetically engineered murine/human chimeric monoclonal antibodyB A Brown, G L Davis, J Saltzgaber-Muller, et al.
Pageof 23